Vanessa Raymont
MBChB MSc MRCPsych
Associate Professor, R&D Director Oxford Health NHS Foundation Trust
- Honorary Senior Clinical Research Fellow, University of Edinburgh
- Honorary Consultant Psychiatrist
My clinical and research interests are in traumatic brain injury, and memory disorders and dementia, as well as clinical trials in cognitive impairment, having worked for over 25 years in clinical trials in the UK and US.
I am currently the Principal Investigator for the Synaptic Health in Neurodegeneration (SHINE) and Brains for Dementia Research (BDR) studies and multiple commercial early and late phase dementia clinical trials. I am Chief Investigator on the Deep and Frequent Phenotyping (DFP) study, a NHIR-funded study assessing the use of sertraline to prevent post-head injury depression (STOP-D) and am co-lead for the REAl world Dementia OUTcomes (READ-OUT) blood biomarker study that is part of the Alzheimer's Research UK Blood Biomarker Challenge. I am an associate director of Dementia Platforms UK, and workstream lead for the Trials Delivery Framework. I serve as a Commissioner for the Commission on Human Medicines and am co-Deputy Chair of the NIHR Dementia Translational Research Collaboration.
Recent publications
-
Journal article
Blane J. et al, (2025), Sci Rep, 15
-
Journal article
Gillis G. et al, (2025), Hum Brain Mapp, 46
-
Preprint
Blane J. et al, (2024)
-
Journal article
Lennon MJ. et al, (2024), J Neurol Neurosurg Psychiatry
-
Journal article
Raymont V., (2024), J Neurotrauma, 41
-
Preprint
Gillis G. et al, (2024)
-
Journal article
Low A. et al, (2024), JAMA Netw Open, 7
-
Journal article
Jafarian A. et al, (2024), Hum Brain Mapp, 45
-
Journal article
Creswell C. et al, (2024), Lancet Psychiatry, 11, 193 - 209
-
Journal article
Karvandi E. et al, (2023), BMJ Open, 13
-
Artificial Intelligence for Dementia Prevention
Journal article
NEWBY D. et al, (2023), Alzheimer's and Dementia
-
Journal article
O'Donoghue MC. et al, (2023), BMJ Open, 13
-
Journal article
Woods M. et al, (2023), Br J Hosp Med (Lond), 84, 1 - 3
-
Journal article
Lennon MJ. et al, (2023), J Neurotrauma, 40, 1423 - 1435
-
Preprint
Tari B. et al, (2023)
-
Journal article
Natarajan A. et al, (2023), Syst Rev, 12
-
Preprint
Tari B. et al, (2023)
-
Preprint
Phiri P. et al, (2023)
-
Preprint
Delanerolle G. et al, (2023)
-
Journal article
Tari B. et al, (2023), Front Public Health, 11
-
Journal article
Lanskey JH. et al, (2022), BMJ Open, 12
-
Journal article
Taylor L. et al, (2022), Trials, 23
-
Journal article
Manca R. et al, (2022), Acta Neuropsychiatr, 34, 276 - 281
-
Journal article
Delanerolle G. et al, (2022), World J Psychiatry, 12, 1233 - 1254
-
Preprint
Griffanti L. et al, (2022)
-
Preprint
Taylor L. et al, (2022)
-
Preprint
Phiri P. et al, (2022)
-
Preprint
Delanerolle G. et al, (2022)
-
Journal article
Raymont V. and Fleminger S., (2022), Cogn Neuropsychiatry, 27, 289 - 295
-
HISTORY OF INTIMATE PARTNER VIOLENCE IS ASSOCIATED WITH ADVERSE MENTAL HEALTH OUTCOMES IN MID-LIFE
Conference paper
Jenkins N. et al, (2022), JOURNAL OF NEUROTRAUMA, 39, A33 - A34
-
Preprint
O’Donoghue MC. et al, (2022)
-
Journal article
Delanerolle G. et al, (2022), World J Psychiatry, 12, 739 - 765
-
Preprint
Delanerolle G. et al, (2022)
-
Preprint
Natarajan A. et al, (2022)
-
Preprint
Delanerolle G. et al, (2022)
-
Preprint
Shetty A. et al, (2022)
-
Journal article
Shetty A. et al, (2022), Front Digit Health, 4
-
Journal article
Griffanti L. et al, (2022), Neuroimage Clin, 36
-
Journal article
Manca R. et al, (2022), Front Psychiatry, 13
-
Journal article
Pitt J. et al, (2021), Alzheimer's & Dementia, 17
-
Journal article
Blane J. et al, (2021), Alzheimers Dement, 17 Suppl 11
-
Study protocol: SOcial LImitations Turn Up DEmentia (SOLITUDE)—Impact of COVID‐19 social isolation on patients’ cognition and mental health and on carers’ wellbeing
Journal article
Manca R. et al, (2021), Alzheimer's & dementia : the journal of the Alzheimer's Association, 17
-
Journal article
Manca R. et al, (2021), Alzheimers Dement, 17 Suppl 7
-
Journal article
Lennon MJ. et al, (2021), J Alzheimers Dis
-
Journal article
Delanerolle G. et al, (2021), EClinicalMedicine, 38
-
Journal article
Burns DK. et al, (2021), The Lancet Neurology, 20, 537 - 547
-
Preprint
Lanskey JH. et al, (2021)
-
Preprint
Delanerolle G. et al, (2021)
-
Journal article
Chau SWH. et al, (2021), BMC Public Health, 21
-
Journal article
Phiri P. et al, (2021), EClinicalMedicine, 34
-
Journal article
Delanerolle G. et al, (2021), World J Psychiatry, 11, 58 - 62
-
Journal article
Baksh RA. et al, (2021), Psychol Aging, 36, 288 - 297
-
Journal article
Delanerolle G. et al, (2021), British Journal of Neuroscience Nursing, 17, 13 - 16
-
Journal article
Delanerolle G. et al, (2021), Womens Health (Lond), 17
-
Journal article
Delanerolle G. et al, (2021), Womens Health (Lond), 17
-
Journal article
Mendis SB. et al, (2021), Front Neurol, 12
-
Conference paper
Hapangama D. et al, (2020), INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 30, A52 - A53
-
Journal article
Calvin CM. et al, (2020), Alzheimers Res Ther, 12
-
Journal article
Raymont V. and Thayanandan T., (2020), Minerva Med
-
Journal article
Delanerolle G. et al, (2020), British Journal of Neuroscience Nursing, 16, 200 - 202
-
Chapter
Terry GE. et al, (2020), PET and SPECT of Neurobiological Systems, 319 - 426
-
Journal article
Jolly AE. et al, (2019), Neuroimage Clin, 24
-
Journal article
Goel V. et al, (2019), J Cogn Neurosci, 1 - 14
-
Partnership in practice: an innovative Brain Health Centre
Conference paper
O'DONOGHUE M. et al, (2019)
-
Journal article
Pardini M. et al, (2019), CNS Spectr, 1 - 8
-
Journal article
Koychev I. et al, (2019), BMJ Open, 9
-
Journal article
Eimontaite I. et al, (2018), Neuropsychologia
-
Journal article
Mueller C. et al, (2018), International Journal of Therapy and Rehabilitation, 25, 107 - 119
-
Journal article
Robert Brašić J. et al, (2018), Int J Phys Med Rehabil, 6
-
A preliminary report about the psychological effects of dopamine on people with the syndrome of Gilles de la Tourette. report about the psychological effects of dopamine on people with the syndrome of Gilles de la Tourette
Conference paper
Brasic J. et al, (2017), Journal of Nuclear Medicine, 58
-
Journal article
Goel V. et al, (2017), Neuropsychologia, 99, 236 - 245
-
Journal article
Greenan C. et al, (2016), Trials, 17
-
Journal article
Huey ED. et al, (2016), JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 28, 104 - 111
-
Journal article
Paradiso S. et al, (2016), JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 38, 887 - 899
-
Journal article
Lewis JD. et al, (2015), BRAIN IMAGING AND BEHAVIOR, 9, 456 - 460
-
Journal article
Davis RE. et al, (2015), Psychopharmacology (Berl), 232, 2863 - 2872
-
Journal article
Knutson KM. et al, (2015), Journal of Neuropsychiatry and Clinical Neurosciences, 27, 193 - 198
-
Journal article
Pardini M. et al, (2014), CNS SPECTRUMS, 19, 382 - 390
-
Journal article
Wong D. et al, (2014), Neuropsychopharmacology, 39, 2272 - 2272
-
Journal article
Schneider EB. et al, (2014), NEUROLOGY, 82, 1636 - 1642
-
Journal article
Knutson KM. et al, (2014), HUMAN BRAIN MAPPING, 35, 943 - 953
-
Chapter
Horti AG. et al, (2014), PET and SPECT of Neurobiological Systems, 249 - 319
-
Journal article
Owen GS. et al, (2013), BRITISH JOURNAL OF PSYCHIATRY, 203, 461 - 467
-
Journal article
Dal Monte O. et al, (2013), SOCIAL COGNITIVE AND AFFECTIVE NEUROSCIENCE, 8, 632 - 639
-
Journal article
Wong DF. et al, (2013), Neuroimage, 75, 282 - 290
-
Journal article
Glass L. et al, (2013), CEREBRAL CORTEX, 23, 1663 - 1672
-
Reduced dopamine blockade in the basal ganglia in obsessive-compulsive disorder
Conference paper
Brasic J. et al, (2013), JOURNAL OF NUCLEAR MEDICINE, 54
-
Journal article
Raymont V. et al, (2013), New Journal of Chemistry, 37, 893 - 900
-
Journal article
Rosenberg PB. et al, (2013), Am J Geriatr Psychiatry, 21, 272 - 278
-
Journal article
Knutson KM. et al, (2013), NEUROPSYCHOLOGIA, 51, 686 - 694
-
Journal article
Folio L. et al, (2013), MILITARY MEDICINE, 178, 338 - 345
-
Journal article
Martin-Facklam M. et al, (2013), Neuropsychopharmacology, 38, 504 - 512
-
Journal article
Waechter RL. et al, (2013), NEUROPSYCHOLOGIA, 51, 464 - 471
-
Dopamine release and serotonin interactions in Tourette's syndrome: new relations to obsessive compulsive disorder
Conference paper
Wong DF. et al, (2012), JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 32, S96 - S97
-
Effects of amphetamine-induced dopamine release and raclopride-induced dopamine blockade on psychiatric symptoms and tics of subjects with and without Gilles de la Tourette syndrome
Conference paper
Brasic JR. et al, (2012), JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 32, S92 - S92
-
Correlation of psychiatric symptoms and tics with amphetamine-induced dopamine release (DAR) in the striata of people with Gilles de la Tourette syndrome (TS) and obsessive-compulsive disorder (OCD)
Conference paper
Brasic J. et al, (2012), JOURNAL OF NUCLEAR MEDICINE, 53
-
Imaging biomarkers for the glycine transporter type 1
Conference paper
Wong D. et al, (2012), JOURNAL OF NUCLEAR MEDICINE, 53
-
Cannabinoid Receptor Subtype 1 (CB1) Distribution Correlates with Neuropsychiatric Ratings
Conference paper
Wong DF. et al, (2012), BIOLOGICAL PSYCHIATRY, 71, 258S - 258S
-
Journal article
Brašić JR. et al, (2012), Synapse, 66, 352 - 368
-
Journal article
Pardini M. et al, (2012), TRANSLATIONAL PSYCHIATRY, 2